Fundraising FoxCitizen Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Phagosphagos.orginOct 2025
Phagos develops phage therapy treatments as an alternative to antibiotics, using its Alphagos platform that combines microbiology and AI to design targeted bacterial medicines against antimicrobial resistance.
AgTechAI & Machine LearningBiotechIvry-Sur-Seine, FR
Alexandros Pantalis(Executive Officer, Director)inAdèle James(CTO)in
BoardRobert Kniaz(Director)inXin Ma(Director)Geoffroy Dubus(Director)in
Co-investorsAcurio VenturesBeyond CapitalCapagroEntrepreneur FirstHoxton VenturesAgFunder+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.